宜宾双眼皮加开眼角效果图宜宾做丰胸多少钱,宜宾宝尼达隆鼻多少钱,宜宾割双眼皮那里最好,宜宾平行的双眼皮多少钱,宜宾怎么让鼻子变高,宜宾祛眼袋医院哪里好,宜宾市哪家割双眼皮医院做好

SAN DIEGO (KGTV) — Governor Gavin Newsom’s vaccine safety task force will have to work quickly once the FDA announces a decision on Pfizer’s COVID-19 vaccine candidate.The 11-member panel, officially called the Scientific Safety Review Workgroup, has been tasked with reviewing the safety and efficacy of vaccine trials and rendering a recommendation on their use in California.The workgroup has a difficult mission: review the data thoroughly enough to offer a recommendation independent from the FDA, but do it fast enough to avoid delaying distribution of the vaccine.Pfizer’s emergency use authorization application spans thousands of pages.The workgroup has already reviewed Pfizer’s early-stage clinical trial data from phases 1 and 2 and found no cause for concern, Governor Gavin Newsom said. They’re still waiting to get their hands on the all-important Phase 3 data, which included thousands of participants.Panel member Dr. Rodney Hood, the president of the Multicultural Health Foundation, acknowledged the task force will have to complete its review of the Phase 3 data “very, very quickly.” Dr. Hood is one of two members from the San Diego region, along with Dr. Mark Sawyer of Rady Children’s Hospital.“We certainly don't want to introduce any unnecessary delay in the vaccine being available to Californians,” Dr. Sawyer said.The FDA has scheduled a meeting of its vaccine advisory committee, known by its acronym VRBPAC (pronounced verb-pack), on Dec. 10. The agency said it will make Pfizer’s Phase 3 data available at least two days before that meeting.At the end of that meeting, a group of about 20 experts on the advisory committee will vote on whether to recommend emergency authorization of the vaccine. The FDA is expected to issue a decision shortly after, although the agency does not have to abide by the advisory committee’s recommendation.“The California committee is on notice to be ready for a meeting either later in the day on the 10th or on December 11,” said Dr. Sawyer.Dr. Sawyer was recently added to VRBPAC, so he will cast a vote on whether to recommend approval of the vaccine at the national level before participating in California’s process.“It is going to take a few days for the vaccine to really start flowing,” he said. “I don't think the [California] committee is going to introduce extra delay.”The California committee has promised to issue its decision within 24 hours of the FDA’s to avoid slowing down distribution, but that means the members may have as few as three days to review the safety and efficacy data.Federal regulators will spend about three weeks reviewing the thousands of pages of data submitted as part of Pfizer’s application. VRBPAC and the California Scientific Safety Review Workgroup will render decisions based on summaries prepared by the FDA, Dr. Sawyer said.Both doctors say they have confidence in the FDA’s process and acknowledge it would be very unlikely for the California workgroup to break with the agency’s recommendation. They said the mission of their review is to add an extra layer of verification after complaints the Trump administration was exercising political pressure on the FDA.“I think the governor foresaw that it was going to be very important that the general community accept these vaccines, assuming they're approved and are safe and effective, because otherwise we're not going to get out of this pandemic,” Dr. Sawyer said.The doctors say they want to make sure that community acceptance extends across all demographics, so they’ll be looking closely at the numbers to see if various ethnic or racial groups had different responses to the vaccine.Based on research on past vaccines, a differential response is not expected, Dr. Hood said. However, COVID-19 does strike Latinos and African-Americans more severely, making vaccine acceptance among minority communities all the more critical.“I want to look at the data, get an assessment of risk-benefit and the question I ask is, would I take it? Number one. Number two, if I would take it, would I recommend it to my family?” he said.The doctors said they will also closely examine reports of side effects.Early data suggests both Pfizer and Moderna’s candidates have somewhat harder-hitting side effects than the typical flu vaccine. Dr. Sawyer compared the side effects to the recent shingles vaccine.“Your arm hurts for a day or two. You may not feel well. You may feel a little bit under the weather for the first 24 hours. You could even have a mild fever or headache,” he said, noting those symptoms typically resolve within 24 to 48 hours based on the data available so far.“That's actually a good sign. You want that to happen,” he added.Those sorts of short-term side effects are signs the body is building a strong immune response. They’re evidence the vaccines work as well as advertised, but the doctors say they won’t know for certain until they review the final numbers. 4949

SAN DIEGO (KGTV) - For his 97th birthday one of Ed Stankowski's sons asked if he'd like to visit the USS Midway. The WWII veteran was on the ship for her maiden voyage in 1945. “He shot him down initially and says no I can’t go, you know I can't do that, he says, how am I going to get around?" said Paul Stankowski, another one of Ed's sons. “By 7 o' clock the next morning he was calling my brother up and says, hey when can we go!”Surrounded by four generations, Ed traveled from Wisconsin to San Diego. He got a private tour of the ship and told stories along the way. “Ha! My first night at sea I was seasick like a dog!" remembers Ed.One of the first stops on the tour was visiting the area he once worked in. “I was a Radioman, I was teaching the new recruits the radio code, international Morse code, and the procedure that they use for communicating," said Ed. Ed says he enjoyed his time in the Navy and that being back on the ship brought back memories. “I was very happy to get on a ship like that. It was the biggest ship we had in the Navy at the time and something to be a part of.” 1105

SAN DIEGO (KGTV) - Former Major League Baseball pitcher Esteban Loaiza is now facing a federal charge in his drug possession case. 138

SAN DIEGO (KGTV) - Home sales in San Diego County accelerated in July after declining on an annual basis for more than a year.New data from real-estate tracker CoreLogic shows 3,988 home sales in July, up 10.1 percent from July 2018. That marks the first time since April 2018 that home sales in the county did not decline on an annual basis, when seasonal factors do not impact the data. Meanwhile, the median price for a home sold in the county remained flat over the year at 0,000. In June, the average rate for a 30-year-fixed mortgage fell to 3.8 percent, according to Freddie Mac. That was the first time the rate was below 4 percent since Dec. 2017. It ticked down even lower in July to 3.77 percent. Mark Goldman, a loan officer with C2 Financial, said the lower rates likely helped people increase their buying power by 2 to 3 percent. "That same house is going to cost a little bit less, and help you afford more," he said. "A lot of times when market gives you something like lower rates, the market takes it back in the form of higher prices, and we’re not really seeing that."Goldman said there is less speculation in the market due to concerns that it has leveled off. Still, the median price of 0,000 is pricing people out of the county. For instance, Daniel Obrzut, who grew up in San Diego, bought a three bedroom home in Menifee, in southern Riverside County, for 0,000, where he is raising two daughters. He couldn't find anything similar locally."You're getting houses built in the 1960s, 1970s for 0-0-0,000," he said. "Just couldn't beat it, or it would be three quarters of a million or a million dollar house down here."San Diego County's 10 percent increase in sales activity was the highest in Southern California in July. 1775

SAN DIEGO (KGTV) — FBI San Diego says scammers are using a range of methods to steal money and personal data from people, leveraging fears during the coronavirus pandemic to do so.Fake emails from the Centers for Disease Control and Prevention (CDC) or government offering information about COVID-19 may only deliver malware to computers to steal info or hold computers ransom, the FBI said. Other websites may also claim the same.The FBI also warned of phishing emails regarding the government stimulus checks many Americans are expecting. The emails could be seeking personal data in order to deliver the stimulus relief, only to steal that data. Some phishing emails may involve charitable contributions, general financial relief, airline carrier refunds, fake cures and vaccines, or fake testing kits, the FBI says.RELATED: Accusations of 'unethical' COVID-19 treatment at Carmel Valley medical spaAuthorities also warn of counterfeit coronavirus treatments or equipment, such as N95 masks or personal protection equipment (PPE). Scammers may reach out to sell products claiming to protect individuals from the virus or even treat or cure it.“We want to assure the public that the FBI continues our important work in protecting the American people, specifically those in San Diego and Imperial Counties, despite these unprecedented times," said Omer Meisel, Acting Special Agent in Charge of the San Diego Division of the FBI.RELATED: Instacart employees threaten to strike, say job is currently too risky during COVID-19The FBI recommends individuals do not open attachments or click any links from unfamiliar email addresses or messages. Internet users should also avoid giving any personal information of any kind in response to emails or robocalls.Users can stay on top of potential scams by recognizing legitimate website addresses, misspelled web domains, or suspicious messaging.RELATED: Couple wires 0,000 home down payment to scammerAnyone who believes they are a victim of an internet scam can report cyber crimes on the FBI’s Internet Crime Complaint Center at www.ic3.gov or call the San Diego FBI at 858-320-1800. 2142